The company which signed six new customer licence deals inthe first half expects to sign at least two strategicallyimportant contracts apart from

The company, which signed six new customer licence deals inthe first half, expects to sign at least two "strategicallyimportant" contracts apart from other smaller contracts withboth new and existing customers in the second half, ChiefExecutive Andrew Taylor told Reuters. Intec's customers include AT&T Inc (T.N), Deutsche Telekom(DTEGn.DE) and Vodafone (VOD.L). He said the trend in the second half so far had been sameas before. "We haven't seen any material difference in thefirst month and a half in terms of customer behaviour comparedto the first half." For the six months ended March 31, adjusted pretax profitrose to 11.1 million pounds ($17.5 million) from 2.2 millionpounds in the year-ago period Revenue rose 40 percent to 80.3 million pounds. "The management have a much tighter grip on the businessand pipeline, and are therefore able to plan more effectively,"Numis Securities analyst David Toms said.

Revenue from the Americas rose 35 percent to 36.5 millionpounds, helped by a key contract win in the second half of2008, CEO Taylor said. Taylor said Intec had a significant pipeline cover in NorthAmerica. "It doesn't guarantee that it would translate intorevenue but we've got more than four times pipeline cover,which is pretty important as our key metrics for futureperformance." CURRENCY GAINS There was a significant benefit from currency translationwith more than 90 percent of revenue generated from outside theUK, the company said. On constant currency basis, Intec's adjusted pretax profitwas up 73 percent, while revenue was up by 15 percent.

UBS analyst Chris Grundberg said, "The level of revenuegrowth suggests Intec is taking market share, particularly inthe United States." He raised his rating on the stock to "buy" from "neutral". Intec shares were up 10 pence at 52 pence by 1108 GMT onThursday on the London Stock Exchange. The shares have gained 62 percent since the start of theyear to Wednesday's close, outperforming a 24 percent rise inFTSE Small Cap Index .FTSC ($1=.6329 Pound) (Editing by Gopakumar Warrier) Stocks. DUBLIN--(Business Wire)--Research and Markets( http://) hasannounced the addition of the "US Stem Cell Market Analysis" report to theiroffering. Stem cell therapy - the emerging therapy area that is drawing the attention ofthe pharmaceutical players worldwide - refers to the therapy wherein a damagedtissue that cannot heal itself is repaired by the use of stem cell.